Fig. 1
From: Novel heavily fucosylated glycans as a promising therapeutic target in colorectal cancer
IHC staining of HFGs by anti-HFG mAb in NATs and tumor tissues of three patients with CRC. In patient-19, both the tumor tissue a and NAT b are positively stained. In patient 5, the tumor tissue c and NAT d are positively and negatively stained, respectively. In patient-21, both the tumor tissue (e) and NAT f are negatively stained. CRC colorectal cancer, HFG heavily fucosylated glycan, IHC immunohistochemistry, NAT normal tissue adjacent to tumor